The highly selective cyclo-oxygenase 2 inhibitor rofecoxib demonstrates anti-tumour effects in Lewis lung cancer cell line and anti-angiogenic effects in vitro
Gespeichert in:
Verfasser / Beitragende:
[S. Qadri, J. Wang, K. Redmond, A. O'Donnell, T. Aherne, H. Redmond]
Ort, Verlag, Jahr:
2002
Enthalten in:
Irish Journal of Medical Science, 171(2002-07-01), 69-69
Format:
Artikel (online)
Online Zugang: